{"title":"Alphabet launches AI company to discover new drugs","link":"https://arstechnica.com/?p=1810629","date":1636127177000,"content":"<div>\n<figure>\n  <img src=\"https://cdn.arstechnica.net/wp-content/uploads/2021/11/deepmind-800x533.jpg\" />\n      <p><a href=\"https://cdn.arstechnica.net/wp-content/uploads/2021/11/deepmind.jpg\">Enlarge</a> <span>/</span> Demis Hassabis, CEO of Google's artificial intelligence (AI) startup DeepMind, speaks during a press conference on March 8, 2016 in Seoul, South Korea. (credit: Getty Images)</p>  </figure>\n\n\n\n\n\n\n<div><a name=\"page-1\"></a></div>\n<p>Google owner Alphabet has launched an artificial intelligence company to discover new drugs.</p>\n<p>UK-registered Isomorphic Labs will use technology from its sister company DeepMind “to accelerate drug discovery, and ultimately, find cures for some of humanity’s most devastating diseases,” said Demis Hassabis, the head of DeepMind, in a blog post. He added that he would also become the chief executive of Isomorphic Labs.</p>\n<p>Scientists around the world were awed in July when DeepMind unveiled how its AlphaFold2 technology could be used to predict the shape of <a href=\"https://arstechnica.com/science/2021/07/google-turns-alphafold-loose-on-the-entire-human-genome/\">every protein in the human body</a> with almost perfect accuracy.</p></div><p><a href=\"https://arstechnica.com/?p=1810629#p3\">Read 10 remaining paragraphs</a> | <a href=\"https://arstechnica.com/?p=1810629&amp;comments=1\">Comments</a></p>","author":"Financial Times","siteTitle":"Ars Technica","siteHash":"5b0ddf6e8923e49262a7894cfd77962733e43fbcc565a103b48373820b310636","entryHash":"4b2d1099055ef226faee27b72392c0ef861059a8b1e6187d1a40c8b486740d5d","category":"Tech"}